» Articles » PMID: 34220215

Interrogation of SrtA Active Site Loop Forming Open/close Lid Conformations Through Extensive MD Simulations for Understanding Binding Selectivity of SrtA Inhibitors

Overview
Specialty Biology
Date 2021 Jul 5
PMID 34220215
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

is a gram positive, deadly spore forming bacteria causing anthrax and these bacteria having the complex mechanism in the cell wall envelope, which can adopt the changes in environmental conditions. In this, the membrane bound cell wall proteins are said to progressive drug target for the inhibition of . Among the cell wall proteins, the SrtA is one of the important mechanistic protein, which mediate the ligation with LPXTG motif by forming the amide bonds. The SrtA plays the vital role in cell signalling, cell wall formation, and biofilm formations. Inhibition of SrtA leads to rupture of the cell wall and biofilm formation, and that leads to inhibition of and thus, SrtA is core important enzyme to study the inhibition mechanism. In this study, we have examined 28 compounds, which have the inhibitory activity against the SrtA for developing the 3D-QSAR and also, compounds binding selectivity with both open and closed SrtA conformations, obtained from 100 ns of MD simulations. The binding site loop deviate in forming the open and closed gate mechanism is investigated to understand the inhibitory profile of reported compounds, and results show the closed state active site conformations are required for ligand binding specificity. Overall, the present study may offer an opportunity for better understanding of the mechanism of action and can be aided to further designing of a novel and highly potent SrtA inhibitors.

Citing Articles

Structure-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation of EGFR for the Clinical Treatment of Glioblastoma.

Bhrdwaj A, Abdalla M, Pande A, Madhavi M, Chopra I, Soni L Appl Biochem Biotechnol. 2023; 195(8):5094-5119.

PMID: 36976507 DOI: 10.1007/s12010-023-04430-z.


Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries.

Selvaraj C, Chandra I, Singh S Mol Divers. 2021; 26(3):1893-1913.

PMID: 34686947 PMC: 8536481. DOI: 10.1007/s11030-021-10326-z.


Identification of a Chitooligosaccharide Mechanism against Bacterial Leaf Blight on Rice by In Vitro and In Silico Studies.

Siriwong S, Thepbandit W, Huy Hoang N, Papathoti N, Teeranitayatarn K, Saardngen T Int J Mol Sci. 2021; 22(15).

PMID: 34360756 PMC: 8347687. DOI: 10.3390/ijms22157990.

References
1.
Raskevicius V, Kairys V . Predicting Isoform-specific Binding Selectivities of Benzensulfonamides Using QSAR and 3D-QSAR. Curr Comput Aided Drug Des. 2016; 13(1):75-83. DOI: 10.2174/1573409912666161129153820. View

2.
Lorca M, Morales-Verdejo C, Vasquez-Velasquez D, Andrades-Lagos J, Campanini-Salinas J, Soto-Delgado J . Structure-Activity Relationships Based on 3D-QSAR CoMFA/CoMSIA and Design of Aryloxypropanol-Amine Agonists with Selectivity for the Human β3-Adrenergic Receptor and Anti-Obesity and Anti-Diabetic Profiles. Molecules. 2018; 23(5). PMC: 6099677. DOI: 10.3390/molecules23051191. View

3.
Agrawal R, Jain P, Dikshit S, Bahare R . 3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitors. Comb Chem High Throughput Screen. 2013; 16(4):249-73. DOI: 10.2174/1386207311316040001. View

4.
Selvaraj C, Singh P, Singh S . Molecular insights on analogs of HIV PR inhibitors toward HTLV-1 PR through QM/MM interactions and molecular dynamics studies: comparative structure analysis of wild and mutant HTLV-1 PR. J Mol Recognit. 2014; 27(12):696-706. DOI: 10.1002/jmr.2395. View

5.
Evenseth L, Warszycki D, Bojarski A, Gabrielsen M, Sylte I . In Silico Methods for the Discovery of Orthosteric GABA Receptor Compounds. Molecules. 2019; 24(5). PMC: 6429233. DOI: 10.3390/molecules24050935. View